Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact Of Hladqa1*05 And Hladqa1*03 On Safety And Loss Of Response To Anti-Tnf In Patients With Inflammatory Bowel Disease.
De-La-Cruz JL, Gomollón F, Louro J, López Pérez J, Lourdes Nocito-Colon MM, Gallego Llera B, García-Mateo S, Martínez-Domínguez SJ, Aso Gonzalvo MC, Gargallo-Puyuelo CJ. De-La-Cruz JL, et al. Among authors: gallego llera b. J Crohns Colitis. 2024 Nov 21:jjae178. doi: 10.1093/ecco-jcc/jjae178. Online ahead of print. J Crohns Colitis. 2024. PMID: 39570188
Unravelling the cellular response to the SARS-COV-2 vaccine in inflammatory bowel disease patients on biologic drugs.
Martínez-Domínguez SJ, García-Mateo S, Sainz-Arnal P, Martínez-García J, Gallego-Llera B, Lozano-Limones MJ, Hidalgo S, Gargallo-Puyuelo CJ, Latre-Santos M, Nocito-Colon MML, Martínez-Lostao L, Refaie E, Arroyo-Villarino MT, Del Rio-Nechaevsky M, Ramirez-Labrada A, Pardo J, Gomollón F, Baptista PM. Martínez-Domínguez SJ, et al. Among authors: gallego llera b. Sci Rep. 2023 Dec 27;13(1):23061. doi: 10.1038/s41598-023-50537-y. Sci Rep. 2023. PMID: 38155275 Free PMC article.
Crohn´s disease is an independent risk factor for liver fibrosis in patients with inflammatory bowel disease and non-alcoholic fatty liver disease.
Martínez-Domínguez SJ, García-Mateo S, Gargallo-Puyuelo CJ, Gallego Llera B, Refaie E, Callau P, Mendi C, Baptista PM, Hernández Ainsa M, Arroyo-Villarino MT, López de la Cruz J, Martínez-García J, Alfambra E, Simón Marco MÁ, Ampuero J, Gomollón F. Martínez-Domínguez SJ, et al. Among authors: gallego llera b. Eur J Intern Med. 2024 Feb;120:99-106. doi: 10.1016/j.ejim.2023.10.019. Epub 2023 Oct 21. Eur J Intern Med. 2024. PMID: 37872034
Inflammatory Bowel Disease Is an Independent Risk Factor for Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals.
Martínez-Domínguez SJ, García-Mateo S, Gargallo-Puyuelo CJ, Gallego-Llera B, Callau P, Mendi C, Arroyo-Villarino MT, Simón-Marco MÁ, Ampuero J, Gomollón F. Martínez-Domínguez SJ, et al. Among authors: gallego llera b. Inflamm Bowel Dis. 2024 Aug 1;30(8):1274-1283. doi: 10.1093/ibd/izad175. Inflamm Bowel Dis. 2024. PMID: 37607330 Free PMC article.
Liver Fibrosis in Non-Alcoholic Fatty Liver Disease and Progression to Hepatocellular Carcinoma in Patients with Inflammatory Bowel Disease: A Systematic Review.
Martínez-Domínguez SJ, García-Mateo S, Laredo V, Gargallo-Puyuelo CJ, Gallego Llera B, López de la Cruz J, Gomollón F. Martínez-Domínguez SJ, et al. Among authors: gallego llera b. Cancers (Basel). 2023 Jun 27;15(13):3367. doi: 10.3390/cancers15133367. Cancers (Basel). 2023. PMID: 37444477 Free PMC article. Review.